Serum Institute CEO sets aside Rs 10 crore to support students travelling abroad
New Delhi: Serum Institute of India CEO and owner Adar Poonawalla on Thursday said that he has set aside Rs 10 crore to support students travelling abroad for studies, as a few countries are yet to approve Covishield as an acceptable vaccine for entry without quarantine.
"Dear students travelling abroad, as a few countries are yet to approve Covishield as an acceptable vaccine for travel without quarantine, you may have to incur some costs. I have set aside Rs 10 crore for this...," Poonawalla said in a tweet.
He also shared a link for students to apply for financial support, if needed.
Earlier in July, he had lauded 16 European countries for recognising Covishield as an acceptable vaccine for entry.
Read also: Serum Institute gets expert panel nod to phase 2, 3 trial of Covovax for 2-17 years old
"It is indeed good news for travellers, as we see sixteen European countries recognising Covishield as an acceptable vaccine for entry. However, despite being vaccinated, entry guidelines might vary from country to country, so do read up before you travel," Poonawalla had said in a tweet.
Read also: Serum Institute, CII to work together for expansion of COVID vaccination in small towns, rural areas
